PBM audits can flag claims where the pharmacist, not a physician, is the prescriber of record. Naloxone furnished under a state pharmacist protocol, flu and strep treatment authorized through a test-and-treat protocol, and self-administered hormonal contraceptives furnished at the pharmacy counter all rest on a pharmacist's own state-granted prescriptive authority, not an outside prescription. A PBM claims system built around physician NPIs can flag these claims as missing a valid prescriber and open them to recoupment even when the pharmacist followed state law exactly.
Naloxone Claims Under a State Protocol
California authorizes a pharmacist to furnish an opioid antagonist without an individual prescription under Business and Professions Code Section 4052.01. The pharmacist must follow the protocol the Board of Pharmacy adopted at 16 CCR Section 1746.3: screen the recipient with three required questions, complete at least one hour of opioid-antagonist training, provide counseling the recipient cannot waive, and keep the medication record for at least three years. With the patient's consent, the pharmacist notifies the primary care provider. That protocol is the pharmacist's own prescribing authority. A PBM auditor who asks a pharmacy for the prescriber's order on a naloxone claim is asking for a document that does not exist, because under state law the pharmacist is the prescriber.
Test-and-Treat Claims for Flu and Strep
Business and Professions Code Section 4052.4 lets a California pharmacist perform a CLIA-waived point-of-care test for influenza, strep throat and several other conditions inside a pharmacy licensed as a clinical laboratory. The statute authorizes the test itself. Furnishing the antiviral or antibiotic that follows a positive result takes a separate authority: a collaborative arrangement with a prescriber, or the pharmacist's own recognition as an Advanced Pharmacist Practitioner under Section 4052.6, which lets that pharmacist initiate drug therapy and requires written notice to the patient's diagnosing prescriber. A test-and-treat claim should carry two separate records: the testing protocol and the prescribing authority. A gap in either one is its own audit finding, in a desk review or an onsite review, as Desk Audits vs On-Site Audits: How PBM Review Types Differ explains.
Self-Administered Contraception Claims
Business and Professions Code Section 4052.3(a)(1) lets a pharmacist furnish self-administered hormonal contraceptives, oral, transdermal, vaginal or depot injection, under a protocol the Board of Pharmacy and the Medical Board of California approved jointly. The protocol requires a self-screening tool scored against the federal Medical Eligibility Criteria for Contraceptive Use, a blood-pressure check when a combined hormonal product is requested, and a record of that self-screening tool kept for at least three years. The pharmacist notifies the patient's primary care provider, or gives the patient a written record when the patient has no primary care provider or cannot provide that provider's contact information. The claim's prescriber is the furnishing pharmacist, documented through that protocol rather than a written prescription from an outside clinician.
What a PBM Audit Expects on the Record
State law, not a PBM's claims-adjudication edit, decides whether a pharmacist lawfully dispensed a claim under a standing order, a statewide protocol, or an Advanced Pharmacist Practitioner designation. A PBM's own provider manual can still require documentation before it pays the claim, a separate question from whether the dispensing itself was lawful. A pharmacy relying on pharmacist-prescribed authority should keep the underlying protocol, the training certificate and the patient-specific record the regulation requires on file, ready to produce whether the request comes as PBM Invoice Audit: Proving Your Purchases or as PBM Onsite Audit: How to Prepare for the Auditor Visit. An unresolved finding on these claims carries the same escalation path as any other PBM finding, including network termination in repeat cases.
A payer's claim edit is not a ruling on what state law allows a pharmacist to prescribe.
Health Law Alliance has represented 2,500+ clients nationwide.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel upon receiving a PBM audit notice that challenges pharmacist-prescribed claims. Early legal intervention can protect the pharmacy's rights, ensure the response separates the pharmacist's prescribing authority from the underlying testing or furnishing protocol, avoid inadvertent admissions about documentation gaps, preserve relevant defenses, and allow counsel to communicate with the auditor on the pharmacy's behalf through any audit appeal. Delaying legal representation can significantly affect the outcome of the audit and expose the pharmacy to unnecessary recoupment risk.
How Health Law Alliance Can Help
Health Law Alliance defends pharmacies facing PBM audits, including audits that challenge claims billed under a pharmacist's own prescribing authority. If your pharmacy is facing a PBM audit of pharmacist-prescribed claims, contact us for a free, confidential consultation.
